|
|
|
Volumn 17, Issue 8, 1990, Pages 994-1002
|
|
Termination of slow acting antirheumatic therapy in rheumatoid arthritis: A 14-year prospective evaluation of 1017 consecutive starts
|
|
Author keywords
adverse reactions; methotrexate; prognosis; rheumatoid arthritis; saard; treatment
|
|
Indexed keywords
AURANOFIN;
AUROTHIOMALATE;
GOLD SALT;
HYDROXYCHLOROQUINE;
METHOTREXATE;
PENICILLAMINE;
ADULT;
ADVERSE DRUG REACTION;
AGED;
ARTICLE;
FEMALE;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROGNOSIS;
RHEUMATOID ARTHRITIS;
ANTI-INFLAMMATORY AGENTS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIRHEUMATIC AGENTS, GOLD;
ARTHRITIS, RHEUMATOID;
FEMALE;
GOLD SODIUM THIOMALATE;
HUMAN;
HYDROXYCHLOROQUINE;
MALE;
METHOTREXATE;
MIDDLE AGE;
PENICILLAMINE;
PROGNOSIS;
PROSPECTIVE STUDIES;
REGRESSION ANALYSIS;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TIME FACTORS;
|
|
EID: 0025080342
PISSN: 0315162X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (330)
|
|
References (0)
|
